The future direction of MI treatment and rehabilitation is based on the novel approaches of biotechnology and medicine. In the last few years, more targeted approach such as stem cell treatment to repair infarcts has been studied. The atherosclerotic coronary vascular disease is becoming one of the top leading causes of death in the world. Stem cell therapy is under scrutiny regarding its scope of use, to limit myocardial damage and possibly regenerate myocardium in patients with Acute Myocardial Infarction (AMI).
Two types of categories of stem cells viz. bone marrow mononuclear cells and cardiac stem cells have been used in the study to verify whether patients with myocardial infarctions and ischemic cardiomyopathies show any benefits. Hematopoietic and mesenchymal ‘progenitor’ stem cells from bone marrow stem cells have shown a capacity to limit the size of the infarct, whereas…
